| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |